Business Context and Reporting Period
This Form 8-K Current Report was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on March 11, 2024, covering events that occurred on March 7, 2024. The filing addresses significant changes to the composition of the Board of Directors, including a resignation and two new appointments, as well as the restructuring of board committees.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance changes. However, it discloses specific director compensation terms:
- Annual Retainer: $40,000 per year for each new director (Omar Jimenez and Ryan L. Smith).
- Committee Chair Fees: $10,000 per year for Mr. Jimenez (Audit Committee Chair) and $10,000 per year for Mr. Smith (Compensation and Nominating Committee Chair).
- Payment Terms: Compensation is paid quarterly in arrears. Directors may elect to receive 50% in cash and 50% in stock, or 100% in cash with 50% accrued until the company raises an aggregate of $1 million from any source.
Material Changes Versus Prior Period
The following material changes to the Board of Directors occurred effective March 7, 2024:
- Resignation: Sir Marc Feldmann, Ph.D., resigned as a member of the Board of Directors and Co-Executive Chairman. The resignation was not due to any disagreement with the company. He will continue as an employee of a subsidiary.
- New Appointments: Omar Jimenez and Ryan L. Smith were appointed as Class II directors. Both are considered independent.
- Board Size: The Board size was set at five (5) members.
- Committee Restructuring: The Strategy and Alternatives Committee and the Risk, Safety and Regulatory Committee were combined into a single committee. The Board now consists of a majority of independent members, and all standing committees (Audit, Compensation, Nominating) now consist of three independent members each.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. The primary focus is on governance compliance and the qualifications of the new directors:
- Omar Jimenez: Selected for his significant business and accounting experience, including roles as CFO for public companies (Golden Matrix Group, NextPlay Technologies) and his status as a CPA and CGMA. He is designated as the Audit Committee Financial Expert.
- Ryan L. Smith: Selected for his experience in public company fundraising and the energy sector, including his current role as CEO of U.S. Energy Corp.
- Indemnification: The company plans to enter into standard indemnification agreements with the new directors.
Important Facts for Investor Verification
- Verify the trading symbol ATNF (Common Stock) and ATNFW (Warrants) on the NASDAQ Stock Market.
- Confirm the new Board composition: Lawrence Steinman (Executive Chairman), James N. Woody, Blair Jordan (Lead Independent Director), Omar Jimenez, and Ryan L. Smith.
- Note the condition for accrued cash compensation: 50% of cash fees are deferred until the company raises an aggregate of $1 million from any source.
- Review the attached Offer Letters (Exhibits 10.1 and 10.2) for complete terms of director compensation.